Prediction of Therapeutic Potential of CD19 CAR-T Cells for LBCL By Histone Mark Analyses of Core Epigenetic Programming
Salvatore Fiorenza(Fred Hutch Cancer Center), Cameron J. Turtle(The University of Sydney), Jordan Gauthier(Seattle Cancer Care Alliance), Erik L. Kimble(University of Washington), David G. Maloney(Fred Hutch Cancer Center), Steven Henikoff(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jean Yang(The University of Sydney), Alexandre V. Hirayama(University of Washington), Delaney Kirchmeier(Fred Hutch Cancer Center), Janaki Purushe(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Stanley R. Riddell(Fred Hutch Cancer Center), Yue Cao(The University of Sydney), Derek H. Janssens(Van Andel Institute), Akira Nguyen-Shaw(The University of Sydney), Ye Zheng(Fred Hutch Cancer Center)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Predicting Deleterious Amino Acid Substitutions
|Genome Research|2001|2.7k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k